Male mastectomy for gynaecomastia is a surgical procedure to remove excess glandular breast tissue in males, restoring a flatter, more masculine chest contour. Gynaecomastia — the benign enlargement of male breast tissue — is relatively common, affecting males across all age groups, and can cause significant physical discomfort and psychological distress. This article covers when surgery is recommended, how the procedure is performed, NHS eligibility criteria, potential risks and recovery, and what patients can expect from long-term outcomes, in line with current UK guidance from NICE, the BNF, and the MHRA.

What Is Gynaecomastia and When Is Surgery Recommended?

Surgery is recommended when gynaecomastia persists beyond 12 months, causes significant physical discomfort, or results in considerable psychological distress, after secondary causes — including testicular tumours, hormonal conditions, and causative medications — have been excluded.

Gynaecomastia is the benign enlargement of glandular breast tissue in males, resulting from an imbalance between oestrogen and androgen activity within breast tissue. It is relatively common, with estimates suggesting it affects a substantial proportion of males at some point during their lifetime, with peaks occurring during the neonatal period, puberty, and older age. The condition can affect one or both breasts and may present with tenderness, firmness, or visible swelling beneath the nipple-areola complex. It is important to distinguish true gynaecomastia (glandular proliferation) from pseudogynaecomastia, which refers to fatty tissue accumulation without true glandular enlargement and is more closely associated with obesity.

In many cases, gynaecomastia is physiological — particularly in adolescents — and may resolve spontaneously, often within 6 to 24 months, without intervention. Persistence beyond 12 months reduces the likelihood of spontaneous regression, as glandular tissue tends to become increasingly fibrotic over time, though adolescent cases may still improve. Secondary causes must always be excluded before considering surgery. These include:

• Medications such as spironolactone, anabolic steroids, antiandrogens (including finasteride and bicalutamide), antipsychotics, cimetidine, opioids, and some antiretrovirals

• Hormonal conditions including hypogonadism, hyperthyroidism, hyperprolactinaemia/pituitary disease, adrenal tumours, and Klinefelter syndrome

• Testicular germ cell tumours and other hCG-secreting neoplasms — an important red-flag cause, particularly in younger males with unilateral or rapidly progressive gynaecomastia

• Liver disease or chronic kidney disease

• Recreational drug use, including cannabis, anabolic steroids, and alcohol

Red-flag features requiring urgent assessment: In accordance with NICE NG12 (Suspected Cancer: Recognition and Referral), men aged 50 and over with a unilateral, firm or hard subareolar mass — with or without nipple changes or discharge — should be referred urgently via the 2-week-wait suspected cancer pathway. An urgent referral should also be considered at any age when there are suspicious features such as skin tethering, a hard or irregular mass, or palpable axillary lymphadenopathy. Male breast carcinoma, though rare, must be excluded.

Baseline investigations should include serum testosterone, LH, FSH, oestradiol, prolactin, beta-hCG, liver function tests, renal function, and thyroid function. Testicular examination is essential, and testicular ultrasound should be arranged if a testicular abnormality is suspected. Breast imaging (mammography or ultrasound) should be arranged where malignancy cannot be excluded clinically. If results are abnormal or the underlying cause remains unclear, referral to endocrinology is appropriate.

Surgery — commonly referred to as male mastectomy or gynaecomastia surgery — is typically recommended when the condition is persistent, causing significant physical discomfort, or resulting in considerable psychological distress. NICE CKS (Gynaecomastia) acknowledges that psychological impact — including poor body image, anxiety, and social withdrawal — is an important consideration in management decisions. Surgery may also be indicated when conservative measures, including addressing underlying causes or discontinuing causative medications, have failed to produce adequate improvement.

In early or painful gynaecomastia, short-course medical therapy with tamoxifen is sometimes used under specialist supervision. It is important to note that tamoxifen is not licensed for this indication in the UK and its use is therefore off-label; it should only be initiated by a specialist following a careful assessment of risks and benefits, in line with BNF and MHRA/EMC guidance.

How Male Mastectomy for Gynaecomastia Is Performed

Subcutaneous mastectomy via a periareolar incision is the standard technique, removing the glandular disc whilst preserving the nipple-areola complex; liposuction and skin excision are added for more advanced cases with excess fat or skin redundancy.

Male mastectomy for gynaecomastia is a surgical procedure aimed at removing excess glandular breast tissue, and in some cases excess fat and skin, to restore a flatter, more typically masculine chest contour. The specific technique used depends on the grade and composition of the gynaecomastia, which is commonly classified using the Simon or Webster grading systems. NICE Interventional Procedures Guidance IPG484 addresses the safety and efficacy of subcutaneous mastectomy for gynaecomastia and should inform consent and governance processes.

For mild to moderate cases — where the enlargement is primarily glandular — subcutaneous mastectomy is the standard approach. This involves making a small incision along the lower border of the areola (the periareolar incision), through which the surgeon excises the glandular disc directly. This technique preserves the overlying skin and nipple-areola complex whilst minimising visible scarring.

When excess fatty tissue is also present, liposuction may be performed alongside glandular excision, either through the same incision or via small additional access points. In more advanced cases — particularly Grade III or IV gynaecomastia — where there is significant skin redundancy, additional skin excision may be required. This can involve:

• Periareolar skin excision with purse-string closure

• Vertical or horizontal skin reduction patterns, which leave more visible scars but are necessary to achieve a smooth result

• In severe cases with significant ptosis, free nipple-areola grafting may be required; patients should be counselled that this carries additional risks of depigmentation, altered sensation, and changes to nipple appearance

The procedure is most commonly performed under general anaesthesia, though local anaesthesia with sedation may be suitable for minor cases. Patients should be aware of general anaesthetic risks, including nausea, vomiting, and rare drug reactions, which will be discussed during the pre-operative assessment. Operative time typically ranges from one to two hours.

Pre-operative optimisation is important: patients are strongly encouraged to stop smoking at least four weeks before surgery, as smoking significantly increases the risk of wound complications and impairs healing. A formal venous thromboembolism (VTE) risk assessment should be completed in line with NICE NG89, and appropriate prophylaxis arranged.

A drain may be placed to prevent fluid accumulation, and a compression garment is applied immediately post-operatively to support healing and reduce swelling; the use of drains and the duration of compression garment wear vary by surgeon and unit. The excised tissue should be sent for histopathological analysis to exclude rare but important pathology, including male breast carcinoma — this is particularly important in unilateral or atypical presentations.

NHS Eligibility and Accessing Treatment in the UK

NHS funding for gynaecomastia surgery is not routinely available in many areas; eligibility typically requires persistence beyond 12 months, documented psychological impact, failure of conservative management, and a BMI within a locally specified range.

Access to male mastectomy for gynaecomastia on the NHS is subject to local clinical policies, and eligibility criteria vary considerably across Integrated Care Boards (ICBs) in England, as well as across health boards in Scotland, Wales, and Northern Ireland. In many areas, gynaecomastia surgery is classified as a procedure of limited clinical value (PLCV), meaning NHS funding is not routinely granted unless specific clinical thresholds are met. Patients are advised to check their local ICB or health board policy for the exact criteria applicable to them.

To be considered for NHS-funded surgery, patients typically need to demonstrate:

• Persistent gynaecomastia lasting more than 12 months despite addressing any underlying causes

• Documented psychological impact, such as clinically significant anxiety, depression, or social avoidance; the level of documentation required (including whether a formal mental health assessment is needed) varies by local policy

• Failure of conservative management, including medication review and lifestyle modification

• A BMI within a locally specified acceptable range; thresholds vary by ICB and should be confirmed with the referring clinician. It is also important to distinguish true gynaecomastia from pseudogynaecomastia, as the latter may be better addressed through weight management rather than surgery

The referral pathway typically begins with a GP consultation. The GP will arrange baseline investigations — including serum testosterone, LH, FSH, oestradiol, prolactin, beta-hCG, liver function tests, renal function, and thyroid function — alongside testicular examination, and breast imaging or testicular ultrasound where clinically indicated, to exclude secondary causes. If an urgent suspected cancer referral is required under NICE NG12, this takes priority over any elective surgical pathway. If surgery is deemed appropriate and secondary causes have been excluded, a referral to a consultant plastic or breast surgeon is made. Where results are abnormal or the cause is uncertain, referral to endocrinology should be considered before any surgical referral.

Patients who do not meet NHS criteria may choose to pursue treatment privately; costs in the UK vary depending on the complexity of the procedure, the surgical centre, and the region, and are typically quoted in the range of several thousand pounds. Patients are advised to obtain itemised quotations from more than one provider and to confirm what is included (e.g., anaesthetic fees, post-operative garments, follow-up appointments, and histopathology).

It is advisable for patients to discuss their concerns openly with their GP, as early referral and thorough documentation of symptoms and psychological distress can support an NHS funding application where local policies permit.

Risks, Complications and Recovery After Surgery

Common risks include haematoma, seroma, temporary altered nipple sensation, asymmetry, and scarring; most patients return to light activities within one to two weeks and wear a compression vest for four to six weeks.

As with any surgical procedure, male mastectomy for gynaecomastia carries a range of potential risks and complications, which should be discussed thoroughly during the pre-operative consent process in line with NICE IPG484 and local governance requirements. Most complications are minor and manageable, but patients should be aware of both common and rare outcomes.

Common risks include:

• Haematoma (collection of blood beneath the skin) — one of the most frequent early complications, occurring in approximately 2–5% of cases, and may require surgical drainage

• Seroma (fluid accumulation) — particularly common when liposuction is used alongside excision

• Temporary numbness or altered sensation in the nipple-areola complex, which usually resolves within several months

• Asymmetry between the two sides, which may require revision surgery

• Contour irregularities, including dimpling or uneven skin surface

• Hypertrophic or keloid scarring, which is more likely in individuals with a personal or family history of abnormal scarring

Less common but serious risks include infection, wound dehiscence, nipple necrosis (particularly if blood supply is compromised), and venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. VTE risk will be assessed before surgery and appropriate preventive measures arranged in line with NICE NG89. General anaesthesia carries its own small risks, including nausea, vomiting, and rare allergic reactions, which will be discussed at the pre-operative assessment.

Not sure if this is normal? Chat with one of our pharmacists →

When to seek urgent medical attention: Patients should contact their surgical team promptly — or attend an emergency department if unable to reach them — if they notice rapidly increasing swelling or bleeding, spreading redness or warmth around the wound, discharge or wound breakdown, fever above 38°C, or severe uncontrolled pain. Chest pain or shortness of breath should be treated as a medical emergency and patients should call 999 immediately, as these may indicate a pulmonary embolism.

Recovery is generally straightforward for most patients. The majority return to light activities within one to two weeks, though strenuous exercise and heavy lifting should be avoided for four to six weeks. A compression vest is typically worn for four to six weeks to minimise swelling and support the healing tissues; the exact duration will be advised by the surgical team. Bruising and swelling are expected in the first two to four weeks and gradually subside. Most patients are reviewed at two to four weeks post-operatively, with further follow-up at three months to assess the final result.

Regarding driving: patients should not drive until they can perform an emergency stop safely and comfortably, are no longer taking sedating medicines (including opioid analgesia), and have confirmed with their motor insurer that they are covered to drive following surgery.

If you experience any suspected side effects from medicines or medical devices used during your care, these can be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Experiencing these side effects? Our pharmacists can help you navigate them →

Results, Scarring and Long-Term Outcomes

Most patients report high satisfaction with improved body confidence; periareolar scars fade significantly over 12–18 months, and recurrence is uncommon provided underlying causative factors have been addressed.

The majority of patients who undergo male mastectomy for gynaecomastia report high levels of satisfaction with their results, particularly in terms of improved body confidence, reduced self-consciousness, and enhanced quality of life. Studies consistently demonstrate significant improvements in psychological wellbeing following surgery, with reductions in anxiety and social avoidance being among the most commonly reported benefits.

In terms of physical outcomes, the chest contour is typically noticeably flatter and more defined once post-operative swelling has fully resolved — a process that can take three to six months. Final results are generally considered stable at six to twelve months post-surgery.

Scarring is an important consideration and varies depending on the technique used:

• Periareolar incisions heal well in most patients, as the scar sits along the natural pigment border of the areola and tends to fade significantly over 12–18 months

• Larger skin excision scars are more visible but are positioned to be as discreet as possible; scar maturation takes up to two years

• Silicone gel sheets, scar massage, and sun protection are commonly recommended options to support scar healing during the maturation period; the evidence for individual scar therapies varies, and patients should follow their surgeon's specific guidance

Sensation: Most patients experience some temporary altered sensation in the nipple-areola complex following surgery. Whilst this usually improves over several months, some patients experience prolonged or, in rare cases, permanent sensory change — particularly following more extensive procedures or free nipple-areola grafting. This should be discussed during the consent process.

Recurrence of gynaecomastia after surgery is uncommon, provided that any underlying causative factors have been addressed. In particular, patients should avoid anabolic steroids, antiandrogens, and other causative medicines or substances, and should maintain a stable weight, as significant weight gain following surgery can lead to re-accumulation of fatty tissue in the chest area and affect the aesthetic result. Patients are therefore encouraged to maintain a healthy lifestyle long-term.

For those considering revision surgery due to residual tissue, asymmetry, or contour irregularities, it is generally advisable to wait at least 6 to 12 months after the initial procedure before reassessment, allowing full healing and tissue settling to occur. The appropriate timing will be guided by the operating surgeon.

Frequently Asked Questions